Pfizer and Allergan are in talks to create the world’s biggest drug company by market value. The problem with this scenario? Pfizer’s take over of Allergan have faced a political backlash in the United States over fears that the deal would lead to the company shifting its headquarters and taxable profits to Ireland. But a Reuters examination of corporate filings in Europe and other information shows the company has been shifting profits generated by American scientists and patients overseas for years. This articles dives into this issue, discussing how exactly Pfizer has shifted U.S. profits overseas for years already.
To read more, click here.